The management of end-stage renal disease in India

Artificial Organs

Volumn 22, Issue 3, 1998, Pages 182-186

  Mani, Muthu Krishna ^a  

^a APOLLO HOSPITALS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

END-STAGE RENAL DISEASE;

DISEASES;

AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

ARTICLE; CADAVER DONOR; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; GRAFT SURVIVAL; HEALTH CARE COST; HEALTH ECONOMICS; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INDIA; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVING DONOR; PRIORITY JOURNAL;

EID: 0031884348     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.1998.06070.x     Document Type: Article

References (10)

1. Living standards. Economist 1996;340(7975):94.
2. Real GDP growth slows down by 0.1 pc. Indian Express, Chennai, 24 January 1997:17.
3. Budget in brief. Indian Express, Chennai, 1 March 1997:1.
4. Center for Monitoring Indian Economy. Basic statistics relating to the Indian economy. Volume 2: States. Bombay: Centre for Monitoring Indian Economy, 1991.
5. Anand K, Kapoor SK, Pandav CS. Cost analysis of a primary health centre in northern India. Natl Med J India 1993;6: 160-3.
6. Bapat U. A study on the psychosocial aspects of chronic renal failure. MA degree project report. Bombay: Tata Institute of Social Sciences, 1984.
7. Srikanthan R, Prabhakaran J, Ramkumar TS, Shivanand Nayak K, Subba Rao B, Ramalingam KS, Mani MK. Cost effectiveness of a low dialysate flow rate in haemodialysis: A short term comparative study. Dial Transplant 1990;19:125-6.
8. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes mellitus. N Engl J Med 1993;329: 977-86.
9. The Diabetes Control and Complications Trial (DCCT) Research Group. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetic Control and Complications Trial. Kidney Int 1995;47:1703-20.
10. Parving HH. Clinical experience in the treatment of diabetic renal disease (type 1 and 2): Summary and concluding remarks. Kidney Int 1994;45(Suppl.45):S165-6.